Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
Phase 2
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Dupont Applied Biosciences
- Target Recruit Count
- 30
- Registration Number
- NCT00007449
- Locations
- 🇺🇸
AIDS Healthcare Foundation, Los Angeles, California, United States
🇺🇸Orange Coast Med Group, Newport Beach, California, United States
🇺🇸Bach and Godofsky, Bradenton, Florida, United States
News
No news found